Relative to T cells modified with only TCR-Msln, T cells engineered to express both TCR-Msln and a Fas IFP preferentially infiltrate tumors, expand/persist and retain function in the TME of tumor-bearing mice. The gene discussed is MSLN; the disease is neoplasm.